HungaroTrial is proud to announce the completion of enrolment in a global Phase III. Breast Cancer trial.
Despite the challenges the COVID-19 pandemic presented we succeed to enrol 140 patents in our sites in Hungary and Romania, which is a significant number of the globally enrolled patients.
As a CRO with more than 20 years of experience supporting Sponsors and life-changing therapies we are glad to be the part of the research for new Oncology treatments.
Share this
